Navigation Links
AHIP Statement on Daschle Nomination

WASHINGTON, Dec. 11 /PRNewswire-USNewswire/ -- Karen Ignagni, President and CEO of America's Health Insurance Plans (AHIP), today issued the following statement in response to the nomination of Senator Tom Daschle to be the next Secretary of the U.S. Department of Health and Human Services:

"The American people will welcome the nomination of Senator Tom Daschle because it signals that the incoming administration intends to prioritize comprehensive health care reform. Senator Daschle is exceptionally well qualified to bring people together in support of universal coverage, cost-containment, and improved quality."

AHIP's Board of Directors last week issued a comprehensive health care reform proposal to cover all Americans, reduce the growth of health care costs, and improve the quality and value of care. To learn more about AHIP's proposal, please visit

America's Health Insurance Plans - Providing Health Benefits to More Than 200 Million Americans

SOURCE America's Health Insurance Plans
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. New statement outlines essentials of heart failure clinics
2. United American Healthcare Corporation Issues Statement on Legal Motion Regarding Stock Repurchase Program
3. Statement on Nomination of Retired Gen. Eric Shinseki by VA Secretary Dr. James B. Peake
4. American Legion, Department of Indiana Releases Statement Concerning Revelations of Illicit Drug Trafficking at Roudebush VA Medical Center
5. Firearms Industry Statement on MN Dept of Agriculture Game Donation Testing
6. American Academy of Dermatology Issues Position Statement on Vitamin D
7. Statement of DNC Chairman Howard Dean on World AIDS Day
8. TFAH Statement: FDA Food Protection Plan is Insufficient
9. Assurant Comments on A.M. Best Ratings Statement; Ratings Continue to Reflect Assurants Solid Financial Position
10. International Formula Council Statement on Melamine and Infant Formulas
11. GPhA Statement on FTC Roundtable on Biogenerics
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: